To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Neurology Devices Market size was valued at USD 14.58 Billion in 2022 and is poised to grow from USD 15.76 Billion in 2023 to USD 29.39 Billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The neurology devices market is characterized by intense competition among key players striving to gain a significant market share. The market is a mix of established multinational companies and smaller regional players focusing on niche segments. These companies are continuously engaged in research and development activities to introduce innovative products and maintain their competitive edge. To stay competitive, companies are investing heavily in research and development to introduce advanced technologies and enhance their product portfolios. They are focused on developing minimally invasive devices, integrating AI and machine learning algorithms, and exploring new applications of neurostimulation and neuroimaging technologies. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent in the market to expand geographic reach, enhance product offerings, and gain a competitive advantage. 'Medtronic (US)', 'Abbott Laboratories (US)', 'Boston Scientific Corporation (US)', 'Koninklijke Philips N.V. (Netherlands)', 'Siemens Healthineers AG (Germany)', 'Stryker Corporation (US)', 'GE Healthcare (US)', 'Johnson & Johnson (US)', 'Zimmer Biomet Holdings, Inc. (US)', 'Nihon Kohden Corporation (Japan)', 'Hitachi, Ltd. (Japan)', 'Brainlab AG (Germany)', 'Elekta AB (Sweden)', 'LivaNova PLC (UK)', 'Nevro Corp. (US)', 'Natus Medical Incorporated (US)', 'Penumbra, Inc. (US)', 'Integra LifeSciences Holdings Corporation (US)', 'Terumo Corporation (Japan)', 'Neuropace, Inc. (US)'

The increasing prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, continues to drive the demand for neurology devices. According to the World Health Organization (WHO), neurological disorders affect millions of people globally, necessitating advanced diagnostic and therapeutic solutions.

Shift towards Minimally Invasive Procedures: There is a notable trend towards minimally invasive procedures in the field of neurology. Minimally invasive techniques offer advantages such as reduced postoperative complications, shorter hospital stays, and quicker recovery times. This trend drives the demand for neurology devices that enable precise interventions with minimal tissue disruption.

North America holds the largest market share in the neurology devices market, primarily due to the presence of well-established healthcare infrastructure, advanced technological advancements, and a high prevalence of neurological disorders. The region's dominance can be attributed to the significant investments in research and development, strong collaborations between industry players and academic institutions, and favorable reimbursement policies.

Feedback From Our Clients

Global Neurology Devices Market

Product ID: SQMIG35A2500